Vitespen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vitespen, covering 2021-06-03 to 2021-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence [Phase 2]